International Journal of Molecular Sciences · 2018 · 76 citations · 31 references
MedicineOncologyPharmacologyCancer PharmacologyCarcinogenesisMolecular OncologyHepatocellular Carcinoma PharmacotherapyOncogenic Signaling PathwaysAnticancer ActivityAnticancer Natural ProductsEpithelial TransitionFlavonoid GlycosidesHepatocellular Carcinoma PathogenesisPhysicochemical PropertiesPhytochemicals In Cancer PreventionPlant Alkaloids
Dendrobium officinale is a precious medicinal herb and health food, and its pharmacological actions have been studied and proved. However, the mechanisms by which its active flavonoid glycosides affect epithelial–mesenchymal transition (EMT) in hepatocellular carcinoma (HCC) cells, such as HepG2 and Bel-7402 cells, have not been previously investigated. Therefore, we investigated whether isoviolanthin extracted from the leaves of Dendrobium officinale inhibits transforming growth factor (TGF)-β1-induced EMT in HCC cells. In this study, the physicochemical properties and structure of isoviolanthin were identified by HPLC, UV, ESIMS, and NMR and were compared with literature data. HCC cells were pretreated with 10 ng/mL TGF-β1 to induce EMT and then treated with isoviolanthin. Herein, we found that isoviolanthin exhibited no cytotoxic effects on normal liver LO2 cells but notably reduced the migratory and invasive capacities of TGF-β1-treated HCC cells. Additionally, isoviolanthin treatment decreased matrix metalloproteinase (MMP)-2 and -9 levels, and remarkably altered the expression of EMT markers via regulating the TGF-β/Smad and PI3K/Akt/mTOR signaling pathways; Western blot analysis confirmed that the effects of the inhibitors SB431542 and LY294002 were consistent with those of isoviolanthin. These findings demonstrate the potential of isoviolanthin as a therapeutic agent for the treatment of advanced-stage metastatic HCC.
31
Andrei V. Bakin, Anne K. Tomlinson, Neil A. Bhowmick et al. · Journal of Biological Chemistry · 2000 · 991 citations · Full text
Global trends and predictions in hepatocellular carcinoma mortality
Paola Bertuccio, Federica Turati, Greta Carioli et al. · Journal of Hepatology · 2017 · 659 citations
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012
Donna L. White, Aaron P. Thrift, Fasiha Kanwal et al. · Gastroenterology · 2016 · 422 citations · Full text